RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model (Q46715452)
Jump to navigation
Jump to search
scientific article published in June 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model |
scientific article published in June 2008 |
Statements
1 reference
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model (English)
1 reference
K M Woods Ignatoski
1 reference
J F Escara-Wilke
1 reference
J-L Dai
1 reference
A Lui
1 reference
W Dougall
1 reference
S Daignault
1 reference
Z Yao
1 reference
J Zhang
1 reference
M L Day
1 reference
E E Sargent
1 reference
E T Keller
1 reference
1 June 2008
1 reference
1 reference
68
1 reference
8
1 reference
820-829
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference